456 related articles for article (PubMed ID: 25093975)
1. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Ekra KA; Shiraishi RW; Tuho MZ; Kouakou JS; Mohamed F; Ettiègne-Traoré V; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
PLoS One; 2014; 9(5):e98183. PubMed ID: 24866468
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
[TBL] [Abstract][Full Text] [Related]
4. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
6. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
7. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
[TBL] [Abstract][Full Text] [Related]
8. Results from a rapid national assessment of services for the prevention of mother-to-child transmission of HIV in Côte d'Ivoire.
Granato SA; Gloyd S; Robinson J; Dali SA; Ahoba I; Aka D; Kouyaté S; Billy DA; Kalibala S; Koné A
J Int AIDS Soc; 2016; 19(5 Suppl 4):20838. PubMed ID: 27443269
[TBL] [Abstract][Full Text] [Related]
9. Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.
McNairy ML; Bashi JB; Chung H; Wemin L; Lorng MA; Brou H; Nioble C; Lokossue A; Abo K; Achi D; Ouattara K; Sess D; Sanogo PA; Ekra A; Ettiegne-Traore V; Diabate CJ; Abrams EJ; El-Sadr WM
Trop Med Int Health; 2017 Apr; 22(4):431-441. PubMed ID: 28101954
[TBL] [Abstract][Full Text] [Related]
10. Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Côte d'Ivoire Between 2012 and 2016.
Touré F; Etheredge GD; Brennan C; Parris K; Diallo MO; Ouffoue AF; Ekra A; Prao H; Assamoua NV; Gnongoue C; Kone F; Koffi C; Kamagaté F; Rivadeneira E; Carpenter D
Pediatr Infect Dis J; 2023 Apr; 42(4):299-304. PubMed ID: 36689665
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme.
Grimsrud A; Kaplan R; Bekker LG; Myer L
Trop Med Int Health; 2014 Sep; 19(9):1029-39. PubMed ID: 25041716
[TBL] [Abstract][Full Text] [Related]
12. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
[TBL] [Abstract][Full Text] [Related]
13. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
[TBL] [Abstract][Full Text] [Related]
14. Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
Auld AF; Blain M; Ekra KA; Kouakou JS; Ettiègne-Traoré V; Tuho MZ; Mohamed F; Shiraishi RW; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
PLoS One; 2016; 11(6):e0157059. PubMed ID: 27275742
[TBL] [Abstract][Full Text] [Related]
15. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
16. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
[TBL] [Abstract][Full Text] [Related]
17. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
[TBL] [Abstract][Full Text] [Related]
19. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
20. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
